Back to LLY
Frank, Rimerman Advisors LLC → LLY
Frank, Rimerman Advisors LLC LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
5
Latest value
$12.8M
Q3 2026
Peak value
$13.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6.5M |
| Q4 2025 | $11.6M |
| Q1 2026 | $9.5M |
| Q2 2026 | $13.3M |
| Q3 2026 | $12.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $12.8M | 11.1K | — | — |
| Q2 2026 | $13.3M | 11.1K | — | — |
| Q1 2026 | $9.5M | 10.3K | — | — |
| Q4 2025 | $11.6M | 10.8K | — | — |
| Q3 2025 | $6.5M | 8.5K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B